LEXICON PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$2.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-06
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $4.90M, a 55.92% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$6.90M.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$5.65M, a 161.89% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$14.00M, a 257.86% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$30.22M, a 304.19% decline from fiscal 2024.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $14.80M, a 129.33% increase from fiscal 2023.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $6.45M, a 8392.11% increase from fiscal 2022.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $76.00K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.00M 10-Q · filed 2026-08-06 | -$7.64M derived: sum of 3 quarters · filed 2026-08-06 | -$21.65M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$6.90M 10-Q · filed 2026-05-07 | -$12.55M derived: sum of 2 quarters · filed 2026-05-07 | -$26.55M derived: sum of 3 quarters · filed 2026-05-07 | -$15.43M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$5.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$19.65M derived: sum of 2 quarters · filed 2026-03-05 | -$8.53M derived: sum of 3 quarters · filed 2026-08-06 | -$30.22M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | -$14.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$2.88M derived: sum of 2 quarters · filed 2026-08-06 | -$24.57M 10-Q · filed 2025-11-06 | -$15.45M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $11.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$10.57M 10-Q · filed 2026-08-06 | -$1.44M derived: sum of 3 quarters · filed 2026-08-06 | $7.43M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$21.69M 10-Q · filed 2026-05-07 | -$12.56M derived: sum of 2 quarters · filed 2026-05-07 | -$3.69M derived: sum of 3 quarters · filed 2026-05-07 | $2.22M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $9.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $18.00M derived: sum of 2 quarters · filed 2026-03-05 | $23.91M derived: sum of 3 quarters · filed 2026-03-05 | $14.80M 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | $8.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $14.78M derived: sum of 2 quarters · filed 2025-11-06 | $5.67M 10-Q · filed 2025-11-06 | $3.02M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-06-30 | $5.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$3.20M 10-Q · filed 2025-08-06 | -$5.85M derived: sum of 3 quarters · filed 2026-03-05 | $261.00K derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-03-31 | -$9.11M 10-Q · filed 2025-05-14 | -$11.76M derived: sum of 2 quarters · filed 2026-03-05 | -$5.65M derived: sum of 3 quarters · filed 2026-03-05 | $116.00K derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2023-12-31 | -$2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $3.46M derived: sum of 2 quarters · filed 2026-03-05 | $9.22M derived: sum of 3 quarters · filed 2026-03-05 | $6.45M 10-K · filed 2026-03-05 | ||||
| 2023-09-30 | $6.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $11.88M derived: sum of 2 quarters · filed 2024-11-13 | $9.11M 10-Q · filed 2024-11-13 | $13.82M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-06-30 | $5.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $3.00M 10-Q · filed 2024-08-02 | $7.71M derived: sum of 3 quarters · filed 2025-03-07 | $8.52M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-03-31 | -$2.77M 10-Q · filed 2024-05-02 | $1.94M derived: sum of 2 quarters · filed 2025-03-07 | $2.75M derived: sum of 3 quarters · filed 2025-03-07 | $614.00K derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2022-12-31 | $4.71M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $5.52M derived: sum of 2 quarters · filed 2025-03-07 | $3.38M derived: sum of 3 quarters · filed 2025-03-07 | $76.00K 10-K · filed 2025-03-07 | ||||
| 2022-09-30 | $810.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$1.33M derived: sum of 2 quarters · filed 2023-11-08 | -$4.64M 10-Q · filed 2023-11-08 | -$5.36M derived: sum of 4 quarters · filed 2024-03-25 | ||||
| 2022-06-30 | -$2.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$5.45M 10-Q · filed 2023-08-04 | -$6.17M derived: sum of 3 quarters · filed 2024-03-25 | -$4.90M derived: sum of 4 quarters · filed 2024-03-25 | ||||
| 2022-03-31 | -$3.31M 10-Q · filed 2023-05-04 | -$4.03M derived: sum of 2 quarters · filed 2024-03-25 | -$2.76M derived: sum of 3 quarters · filed 2024-03-25 | -$9.05M derived: sum of 4 quarters · filed 2024-03-25 | ||||
| 2021-12-31 | -$725.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $549.00K derived: sum of 2 quarters · filed 2024-03-25 | -$5.74M derived: sum of 3 quarters · filed 2024-03-25 | -$14.16M 10-K · filed 2024-03-25 | ||||
| 2021-09-30 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$5.01M derived: sum of 2 quarters · filed 2022-11-09 | -$13.43M 10-Q · filed 2022-11-09 | -$48.68M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2021-06-30 | -$6.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$14.71M 10-Q · filed 2022-08-03 | -$49.96M derived: sum of 3 quarters · filed 2023-03-03 | -$68.21M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2021-03-31 | -$8.42M 10-Q · filed 2022-05-05 | -$43.67M derived: sum of 2 quarters · filed 2023-03-03 | -$61.92M derived: sum of 3 quarters · filed 2023-03-03 | -$44.52M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2020-12-31 | -$35.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | -$53.50M derived: sum of 2 quarters · filed 2023-03-03 | -$36.11M derived: sum of 3 quarters · filed 2023-03-03 | -$20.97M 10-K · filed 2023-03-03 | ||||
| 2020-09-30 | -$18.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$856.00K derived: sum of 2 quarters · filed 2021-11-09 | $14.28M 10-Q · filed 2021-11-09 | $35.02M derived: sum of 4 quarters · filed 2022-03-10 | ||||
| 2020-06-30 | $17.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $32.53M 10-Q · filed 2021-08-06 | $53.27M derived: sum of 3 quarters · filed 2022-03-10 | $66.47M derived: sum of 4 quarters · filed 2022-03-10 | ||||
| 2020-03-31 | $15.14M 10-Q · filed 2021-05-06 | $35.88M derived: sum of 2 quarters · filed 2022-03-10 | $49.08M derived: sum of 3 quarters · filed 2022-03-10 | $43.41M derived: sum of 4 quarters · filed 2022-03-10 | ||||
| 2019-12-31 | $20.74M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $33.94M derived: sum of 2 quarters · filed 2022-03-10 | $28.27M derived: sum of 3 quarters · filed 2022-03-10 | $20.10M 10-K · filed 2022-03-10 | ||||
| 2019-09-30 | $13.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $7.53M derived: sum of 2 quarters · filed 2020-10-30 | -$645.00K 10-Q · filed 2020-10-30 | -$15.65M derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2019-06-30 | -$5.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$13.84M 10-Q · filed 2020-07-29 | -$28.85M derived: sum of 3 quarters · filed 2021-03-12 | -$26.91M derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2019-03-31 | -$8.17M 10-Q · filed 2020-04-27 | -$23.18M derived: sum of 2 quarters · filed 2021-03-12 | -$21.24M derived: sum of 3 quarters · filed 2021-03-12 | -$37.47M derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2018-12-31 | -$15.01M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$13.07M derived: sum of 2 quarters · filed 2021-03-12 | -$29.30M derived: sum of 3 quarters · filed 2021-03-12 | -$19.91M 10-K · filed 2021-03-12 | -$18.86M 10-K · filed 2019-03-15 | |||
| 2018-09-30 | $1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$14.29M derived: sum of 2 quarters · filed 2019-11-07 | -$4.91M 10-Q · filed 2019-11-07 | -$4.70M 10-Q · filed 2018-11-01 | -$5.04M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2018-06-30 | -$16.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$6.84M 10-Q · filed 2019-08-01 | -$6.64M 10-Q · filed 2018-07-30 | -$6.98M derived: sum of 3 quarters · filed 2020-03-12 | $3.55M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2018-03-31 | $9.38M 10-Q · filed 2019-05-01 | $9.47M 10-Q · filed 2018-05-03 | $9.24M derived: sum of 2 quarters · filed 2020-03-12 | $19.78M derived: sum of 3 quarters · filed 2020-03-12 | $22.21M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2017-12-31 | -$137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $10.39M derived: sum of 2 quarters · filed 2020-03-12 | $12.83M derived: sum of 3 quarters · filed 2020-03-12 | -$11.88M 10-K · filed 2020-03-12 | $7.17M 10-K · filed 2018-03-01 | |||
| 2017-09-30 | $10.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $12.96M derived: sum of 2 quarters · filed 2018-11-01 | -$11.74M 10-Q · filed 2018-11-01 | -$16.86M derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2017-06-30 | $2.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30 | -$22.27M 10-Q · filed 2018-07-30 | $22.27M 10-Q · filed 2017-08-01 | -$27.39M derived: sum of 3 quarters · filed 2019-03-15 | -$2.87M derived: sum of 4 quarters · filed 2019-03-15 | |||
| 2017-03-31 | -$24.70M 10-Q · filed 2018-05-03 | $24.70M 10-Q · filed 2017-05-04 | -$29.82M derived: sum of 2 quarters · filed 2019-03-15 | -$5.30M derived: sum of 3 quarters · filed 2019-03-15 | -$7.28M derived: sum of 4 quarters · filed 2019-03-15 | |||
| 2016-12-31 | -$5.12M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $19.40M derived: sum of 2 quarters · filed 2019-03-15 | $17.42M derived: sum of 3 quarters · filed 2019-03-15 | $13.58M 10-K · filed 2019-03-15 | -$27.65M 10-K · filed 2017-03-06 | |||
| 2016-09-30 | $24.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $22.54M derived: sum of 2 quarters · filed 2017-11-08 | $18.70M 10-Q · filed 2017-11-08 | -$18.70M 10-Q · filed 2016-11-07 | $15.43M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | -$1.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | -$5.82M 10-Q · filed 2017-08-01 | -$9.10M derived: sum of 3 quarters · filed 2018-03-01 | -$15.35M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | -$3.84M 10-Q · filed 2017-05-04 | -$7.12M derived: sum of 2 quarters · filed 2018-03-01 | -$13.37M derived: sum of 3 quarters · filed 2018-03-01 | -$11.34M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | -$3.28M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$9.53M derived: sum of 2 quarters · filed 2018-03-01 | -$7.50M derived: sum of 3 quarters · filed 2018-03-01 | -$6.20M 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | -$6.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$4.23M derived: sum of 2 quarters · filed 2016-11-07 | -$2.92M 10-Q · filed 2016-11-07 | $2.40M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2015-06-30 | $2.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $3.33M 10-Q · filed 2016-08-04 | $8.65M derived: sum of 3 quarters · filed 2017-03-06 | $4.75M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2015-03-31 | $1.30M 10-Q · filed 2016-05-05 | $6.62M derived: sum of 2 quarters · filed 2017-03-06 | $2.73M derived: sum of 3 quarters · filed 2017-03-06 | -$1.84M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2014-12-31 | $5.32M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $1.43M derived: sum of 2 quarters · filed 2017-03-06 | -$3.14M derived: sum of 3 quarters · filed 2017-03-06 | -$1.27M 10-K · filed 2017-03-06 | ||||
| 2014-09-30 | -$3.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$8.46M derived: sum of 2 quarters · filed 2015-11-09 | -$6.59M 10-Q · filed 2015-11-09 | -$3.02M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2014-06-30 | -$4.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$2.69M 10-Q · filed 2015-08-07 | $873.00K derived: sum of 3 quarters · filed 2016-03-11 | -$3.56M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2014-03-31 | $1.88M 10-Q · filed 2015-05-05 | $5.44M derived: sum of 2 quarters · filed 2016-03-11 | $1.01M derived: sum of 3 quarters · filed 2016-03-11 | -$2.15M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2013-12-31 | $3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | -$868.00K derived: sum of 2 quarters · filed 2016-03-11 | -$4.02M derived: sum of 3 quarters · filed 2016-03-11 | -$3.12M 10-K · filed 2016-03-11 | ||||
| 2013-09-30 | -$4.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$7.59M derived: sum of 2 quarters · filed 2014-11-06 | -$6.68M 10-Q · filed 2014-11-06 | -$7.58M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-06-30 | -$3.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$2.25M 10-Q · filed 2014-08-07 | -$3.14M derived: sum of 3 quarters · filed 2015-03-12 | -$1.57M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | $905.00K 10-Q · filed 2014-05-08 | $13.00K derived: sum of 2 quarters · filed 2015-03-12 | $1.58M derived: sum of 3 quarters · filed 2015-03-12 | $1.05M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2012-12-31 | -$892.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $678.00K derived: sum of 2 quarters · filed 2015-03-12 | $144.00K derived: sum of 3 quarters · filed 2015-03-12 | $995.00K 10-K · filed 2015-03-12 | ||||
| 2012-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $1.04M derived: sum of 2 quarters · filed 2013-11-12 | $1.89M 10-Q · filed 2013-11-12 | -$4.65M derived: sum of 4 quarters · filed 2014-03-07 | ||||
| 2012-06-30 | -$534.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $317.00K 10-Q · filed 2013-08-01 | -$6.22M derived: sum of 3 quarters · filed 2014-03-07 | -$7.69M derived: sum of 4 quarters · filed 2014-03-07 | ||||
| 2012-03-31 | $851.00K 10-Q · filed 2013-05-10 | -$5.69M derived: sum of 2 quarters · filed 2014-03-07 | -$7.15M derived: sum of 3 quarters · filed 2014-03-07 | -$5.67M derived: sum of 4 quarters · filed 2014-03-07 | ||||
| 2011-12-31 | -$6.54M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$8.01M derived: sum of 2 quarters · filed 2014-03-07 | -$6.52M derived: sum of 3 quarters · filed 2014-03-07 | -$10.37M 10-K · filed 2014-03-07 | ||||
| 2011-09-30 | -$1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $25.00K derived: sum of 2 quarters · filed 2012-11-07 | -$3.82M 10-Q · filed 2012-11-07 | -$1.90M derived: sum of 4 quarters · filed 2013-03-11 | ||||
| 2011-06-30 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$2.36M 10-Q · filed 2012-08-02 | -$433.00K derived: sum of 3 quarters · filed 2013-03-11 | $1.42M derived: sum of 4 quarters · filed 2013-03-11 | ||||
| 2011-03-31 | -$3.85M 10-Q · filed 2012-05-03 | -$1.92M derived: sum of 2 quarters · filed 2013-03-11 | -$70.00K derived: sum of 3 quarters · filed 2013-03-11 | |||||
| 2010-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $3.78M derived: sum of 2 quarters · filed 2013-03-11 | $5.24M 10-K · filed 2013-03-11 | |||||
| 2010-09-30 | $1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-01 | $3.31M 10-Q · filed 2011-11-01 | ||||||
| 2010-06-30 | $1.46M 10-Q · filed 2011-08-09 | |||||||
| 2009-12-31 | $2.79M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |